• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Q-MED AB SOLESTA; AGENT, BULKING, INJECTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Q-MED AB SOLESTA; AGENT, BULKING, INJECTABLE Back to Search Results
Device Problem No Apparent Adverse Event (3189)
Patient Problem Abscess (1690)
Event Date 01/01/2014
Event Type  Injury  
Event Description
A physician reported via a sales representative that a (b)(6) male received solesta (dextranomer/hyaluronic acid) injection into the submucosa of the anal canal as treatment for "horrible" fecal incontinence.Additional medical history included that solesta was considered the "last resort" before having to perform a colostomy.Concurrent medications were not provided.On (b)(6) 2014, the patient received solesta.No antibiotics were administered prophylactically.The patient began having symptoms of an infection soon after solesta injection (timeframe not indicated).He was diagnosed with an abscess and antibiotics were started.The patient did not improve and was evaluated by a gastrointestinal specialist.A flexible sigmoidoscopy was performed; however, the abscess was not drained.The patient was still not improving, so he was seen by a surgeon who observed the infection to be tracking into the patient's pelvis.The patient was taken to the operating room and a colostomy was performed.At the time of this report, the patient was stable and recovering from the events.Causality was not reported.The company felt the events were possibly related to solesta.
 
Manufacturer Narrative
The limited information about the patient's possible underlying condition makes a causality assessment difficult, however, a causality cannot be excluded.The injection procedure per se and the fact that no prophylactic antibiotics were provided may have contributed to the events.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SOLESTA
Type of Device
AGENT, BULKING, INJECTABLE
Manufacturer (Section D)
Q-MED AB
uppsala 0000
SW  0000
Manufacturer (Section G)
Q-MED AB
seminariegatan 21
uppsala 752 28
SW   752 28
Manufacturer Contact
8510 colonnade center dr
raleigh, NC 27615
9198621000
MDR Report Key3763219
MDR Text Key17161841
Report Number3009325614-2014-00015
Device Sequence Number1
Product Code LNM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 04/07/2014,03/17/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA04/07/2014
Distributor Facility Aware Date03/17/2014
Date Report to Manufacturer03/24/2014
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/07/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age80 YR
-
-